We are live on ! Find out more
FP

Flagship Pioneering Portfolio holdings

AUM $1.16B
1-Year Est. Return 67.93%
This Fund
S&P 500
This Quarter Est. Return
+13.52%
1 Year Est. Return
+67.93%
3 Year Est. Return
-39.17%
5 Year Est. Return
-45.89%
10 Year Est. Return
–
AUM
$1.79B
AUM Growth
-$39.2M
Cap. Flow
-$188M
Cap. Flow %
-10.49%
Top 10 Hldgs %
100%
Holding
9
New
–
Increased
–
Reduced
2
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
MRNA icon
Moderna
MRNA
+$141M
2
TMDX icon
Transmedics
TMDX
+$46.5M
3
DNLI icon
Denali Therapeutics
DNLI
+$424K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRNA icon
1
Moderna
MRNA
$21.5B
$995M 55.62%
50,871,524
-7,935,855
-13% -$141M
RUBY
2
DELISTED
Rubius Therapeutics, Inc
RUBY
$364M 20.34%
38,296,526
– –
DNLI icon
3
Denali Therapeutics
DNLI
$3.67B
$139M 7.77%
7,980,263
-25,484
-0.3% -$424K
KLDO
4
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
$87.2M 4.87%
17,360,710
– –
MCRB icon
5
Seres Therapeutics
MCRB
$48.1M
$74.4M 4.16%
1,078,588
– –
EVLO
6
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$74M 4.14%
911,670
– –
AXLA
7
DELISTED
Axcella Health Inc. Common Stock
AXLA
$35.1M 1.96%
349,937
– –
SYRS
8
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$20.3M 1.14%
293,849
– –
TMDX icon
9
Transmedics
TMDX
$2.5B
– –
-2,530,275
Closed -$46.5M

Similar funds

AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
BI
Bramshill Investments Naples, Florida $1.16B AUM 0.86% 1-Year Est. Return
SCP
Sandhill Capital Partners Buffalo, New York $1.16B AUM 12.37% 1-Year Est. Return
SFG
SNS Financial Group Minneapolis, Minnesota $1.16B AUM 13.88% 1-Year Est. Return
GAB
German American Bancorp Jasper, Indiana $1.16B AUM 25.7% 1-Year Est. Return
AMI
Amica Mutual Insurance Providence, Rhode Island $1.16B AUM 21.34% 1-Year Est. Return
FFP
FourThought Financial Partners Venice, Florida $1.16B AUM 24.95% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

Flagship Pioneering's Q4 2019 Portfolio in Review

As of Q4 2019, Flagship Pioneering held 9 positions worth $1.79B, down 2.1% from $1.83B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Flagship Pioneering withdrew a net $188M in Q4 2019, closing 1 position and reducing 2 holdings. Its most notable exit was Transmedics, an estimated $46.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Flagship Pioneering's biggest Q4 2019 reduction was Moderna, cutting an estimated $141M.
  • Flagship Pioneering fully exited Transmedics in Q4 2019, selling an estimated $46.5M.
  • Flagship Pioneering's ten largest holdings make up 100% of its $1.79B portfolio in Q4 2019.
  • Flagship Pioneering opened 0 new positions and closed 1 in Q4 2019.
  • Flagship Pioneering's portfolio value fell 2.1% quarter-over-quarter to $1.79B.

Based on Flagship Pioneering's 13F filing for Q4 2019, filed 13 Feb 2020.